TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $557,000 | +11.0% | 7,400 | -60.4% | 0.00% | 0.0% |
| Q1 2022 | $502,000 | -95.5% | 18,700 | -86.9% | 0.00% | -92.9% |
| Q2 2021 | $11,133,000 | -0.5% | 142,700 | +20.6% | 0.01% | 0.0% |
| Q1 2021 | $11,190,000 | +169.3% | 118,300 | +246.9% | 0.01% | +180.0% |
| Q4 2020 | $4,155,000 | -51.0% | 34,100 | -64.9% | 0.01% | -37.5% |
| Q3 2020 | $8,483,000 | -13.1% | 97,100 | -35.8% | 0.01% | 0.0% |
| Q2 2020 | $9,766,000 | +124.5% | 151,200 | +55.2% | 0.01% | +100.0% |
| Q1 2020 | $4,350,000 | – | 97,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |